Key Details
Price
$45.89Last Dividend
$0.67Annual Revenue
$357.78 BAnnual EPS
$6.47Annual ROE
11.24%Beta
0.39Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Oct 21, 2024Next split:
N/ARecent split:
June 07, 2005Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
WOONSOCKET, R.I., Jan. 3, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) has revealed that its board of directors has given the green light for a quarterly dividend of sixty-six and a half cents ($0.665) for each share of the company's common stock.
Lately, users of Zacks.com have been focusing on CVS Health (CVS). This interest prompts a closer look at what the stock might offer.
New laws being considered in various states and in Washington may lead to higher payments for drugstore chains such as CVS Health, Walgreens, Walmart, and independent pharmacies nationwide.
In the most recent trading session, CVS Health (CVS) finished at $44.36, which is an increase of 1.32% compared to the day before.
The U.S. Department of Justice has filed a lawsuit against CVS. According to Conway Gittens, Wall Street saw a recovery on Thursday, just a day after experiencing its largest decline since August.
Jim Cramer from CNBC shares his daily Mad Dash update.
Investors are hopeful about CVS Health's plans for 2025. However, they are worried about the negative impact of the current economic situation.
WASHINGTON--(BUSINESS WIRE)--Today, the U.S. Department of Justice (DOJ) revealed that it has joined a whistleblower lawsuit filed by Baron & Budd against CVS Pharmacy, which concerns their dangerous practices in dispensing opioids. The DOJ's complaint adds to the claims in the whistleblower case, stating that CVS Pharmacy knowingly filled millions of illegal prescriptions for controlled substances without a valid medical reason.
On Wednesday, the U.S. Department of Justice revealed that it is suing CVS for allegedly filling and charging federal health insurance programs for unlawful opioid prescriptions.
CVS Health (CVS) stock has been falling steadily as the company's problems have worsened. Recently, it has decreased for three weeks in a row, reaching a low of $46.60, which is the lowest point since March 2020.
FAQ
- What is the primary business of CVS Health?
- What is the ticker symbol for CVS Health?
- Does CVS Health pay dividends?
- What sector is CVS Health in?
- What industry is CVS Health in?
- What country is CVS Health based in?
- When did CVS Health go public?
- Is CVS Health in the S&P 500?
- Is CVS Health in the NASDAQ 100?
- Is CVS Health in the Dow Jones?
- When was CVS Health's last earnings report?
- When does CVS Health report earnings?
- Should I buy CVS Health stock now?